Literature DB >> 3037681

Novel cholinesterase expression in the HuH-7 cell line.

T Hada, T Yamamoto, H Imanishi, S Takahashi, Y Amuro, K Higashino, J Sato.   

Abstract

On polyacrylamide gradient gel electrophoresis, normal serum cholinesterase was separated into seven isozymes (I-VII from the anodic to the cathodic side). The enzyme of the conditioned medium of the HuH-7 cell line, established from a human hepatoma, had two main isozymes. The one migrating faster was located slightly to the cathodic side of band II of the normal serum enzyme, and the other, a slower one, electrophoresed at the same position as that of band VI of the normal serum enzyme. Aside from these two isozymes, a faint band with enzyme activity sometimes appeared at a position just cathodic or very close to the position of band I of the normal serum isozymes. The effect of some inhibitors and activators on both the normal serum enzyme and the enzyme of the conditioned medium was similar, but lectin-binding properties of the two enzymes were different with Ricinus communis agglutinin I, concanavalin A and wheat germ agglutinin. These results suggest that the difference in sugar moieties of both enzymes is expressed in D-galactose, D-mannose and N-acetylglucosamine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037681     DOI: 10.1159/000217485

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  4 in total

1.  Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13.

Authors:  M Kris; O Jbilo; C F Bartels; P Masson; S Rhode; O Lockridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

2.  Discrimination of liver cirrhosis from chronic hepatitis by analysis of serum cholinesterase isozymes using affinity electrophoresis with concanavalin A or wheat germ agglutinin.

Authors:  T Hada; T Ohue; H Imanishi; H Nakaoka; A Hirosaki; S Shimomura; M Fujikura; Y Matsuda; T Yamamoto; Y Amuro
Journal:  Gastroenterol Jpn       Date:  1990-12

3.  The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma.

Authors:  J Nakamura; S Yazawa; T Hada; T Asao; H Naitoh; S Takenoshita; M Kosaka; S Akamatsu; T Tachikawa; Y Nagamachi
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

4.  Increased plasma alpha (1 --> 3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma.

Authors:  T Hada; K Fukui; M Ohno; S Akamatsu; S Yazawa; K Enomoto; K Yamaguchi; Y Matsuda; Y Amuro; N Yamanaka
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.